Istanbul Oncology Centres Report Growing Referrals for Precision Cancer Care from African and Middle Eastern Patients

Rising Demand for Precision Oncology in Istanbul

Istanbul's oncology centres are reporting a steady increase in referrals from African and Middle Eastern countries, as patients seek advanced diagnostic and treatment options for cancer. The trend reflects a broader movement toward precision cancer care, where treatments are tailored to the genetic and molecular profile of an individual's tumour.

For many families across the region, Türkiye offers a combination of specialist expertise, modern facilities and geographic proximity that is difficult to match elsewhere. Instead of travelling to Western Europe or North America, patients can often reach Istanbul in a few hours, easing the logistical and emotional burden of treatment abroad.

The growing referrals also highlight Türkiye's role as a regional health hub, where oncology teams work in coordinated, multidisciplinary settings to deliver care that is both advanced and accessible.

What Precision Cancer Care Means in Practice

Precision oncology moves beyond a one-size-fits-all approach. It begins with detailed diagnostics — including genomic testing, advanced imaging and pathology review — to identify the specific characteristics of a patient's cancer. This information helps specialists select treatments that are more likely to be effective and potentially less toxic.

In Istanbul's leading centres, these diagnostics are integrated into a comprehensive care plan. Multidisciplinary tumour boards bring together medical oncologists, radiation oncologists, surgeons, pathologists and radiologists to discuss complex cases and agree on a personalised strategy.

This team-based model is particularly valuable for patients with rare or advanced cancers, where treatment decisions can be nuanced. It also provides a structured second-opinion process for those who have already received a diagnosis elsewhere.

Why African and Middle Eastern Patients Are Choosing Türkiye

Several factors are driving the increase in referrals. Many patients appreciate the ability to access specialist opinions quickly, without the long waiting times sometimes encountered in other health systems. Coordinated care journeys — from initial consultation to diagnostics, treatment and follow-up — are another major draw.

Cultural and religious familiarity also plays a role. Istanbul offers a welcoming environment for patients from diverse backgrounds, with halal food readily available, multilingual support services and a growing network of international patient departments.

For families, the city's connectivity means relatives can visit more easily, providing essential emotional support during treatment. This proximity can make a significant difference in the patient experience.

Multidisciplinary Tumour Boards and Personalised Plans

At the heart of Istanbul's precision oncology approach is the multidisciplinary tumour board. These meetings allow specialists to review each case collectively, weighing the latest evidence and diagnostic findings before recommending a plan.

Treatment plans may include targeted therapies, immunotherapy, advanced radiation techniques or surgery — often in combination. The goal is to align the treatment with the patient's specific cancer biology, overall health and personal preferences.

Patients are typically assigned a coordinator who helps navigate appointments, language interpretation and logistical arrangements. This coordinated care journey is designed to reduce stress for patients and their families, who may be unfamiliar with the local health system.

Advanced diagnostics and team-based decisions can offer clarity and hope, helping patients and families move forward with confidence.

Diagnostics and Technology Supporting Better Decisions

Istanbul's oncology centres invest in modern diagnostic tools, including next-generation sequencing, PET-CT imaging and digital pathology. These technologies provide the detailed information needed to guide precision treatment choices.

Genomic profiling, for example, can reveal mutations that make a tumour susceptible to specific targeted drugs. For some patients, this opens options that may not have been considered otherwise.

Access to clinical trials is another area where Turkish centres are expanding. Participation in research can offer eligible patients additional pathways, always under careful ethical and medical oversight.

While no treatment is guaranteed, the emphasis on accurate diagnosis and individualised planning reflects a commitment to high standards of oncology care.

Practical Considerations for International Patients

Planning cancer treatment abroad requires careful preparation. Patients are advised to gather medical records, imaging and pathology reports in advance, and to communicate openly with the international patient department about their needs and expectations.

It is important to discuss costs, duration of stay and follow-up arrangements before travelling. Many centres provide written treatment plans and cost estimates to help families make informed decisions.

After returning home, continued communication with the treating team can support continuity of care. Some patients also arrange for local oncologists to collaborate with Istanbul-based specialists.

As referrals continue to grow, Istanbul's oncology community remains focused on offering dignified, patient-centred care — providing advanced options and coordinated support for those who choose to travel for treatment.